The neuroscience-based nomenclature child & adolescent (NbN C&A) for psychotropic medications: innovation in progress

Cortese, Samuele, Singh, Manpreet Kaur and Novins, Douglas K (2022) The neuroscience-based nomenclature child & adolescent (NbN C&A) for psychotropic medications: innovation in progress. Journal of the American Academy of Child and Adolescent Psychiatry, 61 (11), 1317-1318. (doi:10.1016/j.jaac.2022.06.002).

Abstract

To address the issues with the current nomenclature of psychotropic agents, which may be misleading or confusing, the Neuroscience-based Nomenclature (NbN) started being developed in 2009. It was introduced as one approach to the classification of pharmacological treatments based on a medication's putative psychopharmacological mechanisms of action derived from preclinical and clinical studies. In 2018, the NbN-Child & Adolescent (NbN C&A) was released. Since then, the NbN C&A has been refined, and its website and app (https://nbnca.com/) have been implemented. JAACAP encourages its authors and readers to consider utilizing the NbN C&A and to keep abreast of its developments over time. This is in line with the core missions of the Journal: to contribute to the translation and implementation of the most up-to-date science into real-world clinical practice. DIVERSITY & INCLUSION STATEMENT: One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented racial and/or ethnic groups in science.

This record has no associated files available for download.

Contributors

Author: Samuele Cortese

Download statistics